Results 281 to 290 of about 1,140,223 (331)

Face to Face With Renal Cell Carcinoma: A Case Report. [PDF]

Cureus
Andrade MA, Caires F, Duarte CC, Santana C, Saldanha C.   +4 more
europepmc   +1 more source

Chromophobe renal cell carcinoma

, 2020
openaire   +1 more source

Targeting SPHK1 in macrophages remodels the tumor microenvironment and enhances anti‐PD‐1 immunotherapy efficacy in colorectal cancer liver metastasis

Cancer Communications, EarlyView.
Abstract Background Colorectal cancer liver metastasis (CRLM) is characterized by an immunosuppressive microenvironment and a blunted response to immunotherapy. Notably, tumor‐associated macrophages (TAMs) play a critical role in modulating immune responses and exhibit significant heterogeneity in CRLM.
Yizhi Zhan, Jinsong Xu, Zhanqiao Zhang, Yating Hu, Yongsheng Li, Junying Qian, Yunyan Ling, Dehua Wu, Haijun Deng, Guoxin Li, Zhiyong Shen, Yuan Fang   +11 more
wiley   +1 more source

Crebanine Induces Cell Death and Alters the Mitotic Process in Renal Cell Carcinoma In Vitro. [PDF]

Int J Mol Sci
Shih HJ, Hsu HC, Liu CT, Chang YC, Yu CY, Sung WW.   +5 more
europepmc   +1 more source

Short‐chain acyl post‐translational modifications in cancers: Mechanisms, roles, and therapeutic implications

Cancer Communications, EarlyView.
Abstract Post‐translational modifications (PTMs) play a pivotal role in epigenetic regulation and are key pathways for modulating protein functionality. PTMs involve the covalent attachment of distinct chemical groups, such as succinyl, crotonyl, and lactyl, at specific protein sites, which alter protein structure, function, stability, and activity ...
Ting Wu, Yingqi Zhao, Xin Zhang, Yuanhe Wang, Qiuchen Chen, Mingrong Zhang, Huan Sheng, Yuying Zhang, Jinyu Guo, Jun Li, Yuxuan Fan, Ziqing Wang, Yalun Li, Haoran Wang, Minjie Wei, Xiaoyun Hu, Huizhe Wu   +16 more
wiley   +1 more source

Molecular Genetics of Renal Cell Carcinoma: A Narrative Review Focused on Clinical Relevance. [PDF]

Curr Oncol
Millan B, Loebach L, Blachman-Braun R, Patel MH, Saini J, Linehan WM, Ball MW.   +6 more
europepmc   +1 more source

Deletion of epithelial HKDC1 decelerates cellular proliferation and impairs mitochondrial function of tumorous epithelial cells thereby protecting from intestinal carcinogenesis

Cancer Communications, EarlyView.
Lea Järke, Saskia Weber‐Stiehl, Kensuke Shima, Karlis Arturs Moors, Jerome Genth, Fenja Amrei Schuran, Lena Best, Markus Tschurtschenthaler, Burkhardt Flemer, Silke Lüschen, Christoph Röcken, Andreas Tholey, Christoph Kaleta, Jan Rupp, Philip Rosenstiel, Felix Sommer   +15 more
wiley   +1 more source

Stereotactic body radiotherapy plus cadonilimab (PD‐1/CTLA‐4 bispecific antibody) as third‐line or beyond therapy for refractory solid tumors: A phase 1b study

Cancer Communications, EarlyView.
Abstract Background Cadonilimab is a humanized immunoglobulin G1 bispecific antibody targeting programmed cell death protein 1 (PD‐1) and cytotoxic T‐lymphocyte‐associated antigen 4 (CTLA‐4). This study aimed to evaluate the safety and efficacy of stereotactic body radiotherapy (SBRT) combined with cadonilimab in patients with advanced recurrent or ...
Yao Xiao, Yuxia Wang, Jun Li, Cheng Cheng, Chunyong Song, Xin Wang, Liyuan Tao, Hongqing Zhuang   +7 more
wiley   +1 more source

CENPT prevents renal cell carcinoma against ferroptosis by enhancing the synthesis of glutathione. [PDF]

Cell Death Dis
Yang H, Zhang Z, Feng N, Zhao K, Zhang Y, Yin X, Zhu G, Wang Z, Yan X, Li X, Li Z, Wang Q, Qi Y, Zhao P, He T, Wang K.   +15 more
europepmc   +1 more source

Correction to "Knowledge of Cytogenetic Analysis for Synovial Sarcoma in Sarcomatoid Variant Renal Cell Carcinoma". [PDF]

Clin Case Rep
europepmc   +1 more source